Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs)
- PMID: 19941649
- PMCID: PMC2787528
- DOI: 10.1186/1748-717X-4-58
Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs)
Abstract
Background: Cervical cancer is treated mainly by surgery and radiotherapy. Toxicity due to radiation is a limiting factor for treatment success. Determination of lymphocyte radiosensitivity by radio-induced apoptosis arises as a possible method for predictive test development. The aim of this study was to analyze radio-induced apoptosis of peripheral blood lymphocytes.
Methods: Ninety four consecutive patients suffering from cervical carcinoma, diagnosed and treated in our institution, and four healthy controls were included in the study. Toxicity was evaluated using the Lent-Soma scale. Peripheral blood lymphocytes were isolated and irradiated at 0, 1, 2 and 8 Gy during 24, 48 and 72 hours. Apoptosis was measured by flow cytometry using annexin V/propidium iodide to determine early and late apoptosis. Lymphocytes were marked with CD45 APC-conjugated monoclonal antibody.
Results: Radiation-induced apoptosis (RIA) increased with radiation dose and time of incubation. Data strongly fitted to a semi logarithmic model as follows: RIA = betaln(Gy) + alpha. This mathematical model was defined by two constants: alpha, is the origin of the curve in the Y axis and determines the percentage of spontaneous cell death and beta, is the slope of the curve and determines the percentage of cell death induced at a determined radiation dose (beta = DeltaRIA/Deltaln(Gy)). Higher beta values (increased rate of RIA at given radiation doses) were observed in patients with low sexual toxicity (Exp(B) = 0.83, C.I. 95% (0.73-0.95), p = 0.007; Exp(B) = 0.88, C.I. 95% (0.82-0.94), p = 0.001; Exp(B) = 0.93, C.I. 95% (0.88-0.99), p = 0.026 for 24, 48 and 72 hours respectively). This relation was also found with rectal (Exp(B) = 0.89, C.I. 95% (0.81-0.98), p = 0.026; Exp(B) = 0.95, C.I. 95% (0.91-0.98), p = 0.013 for 48 and 72 hours respectively) and urinary (Exp(B) = 0.83, C.I. 95% (0.71-0.97), p = 0.021 for 24 hours) toxicity.
Conclusion: Radiation induced apoptosis at different time points and radiation doses fitted to a semi logarithmic model defined by a mathematical equation that gives an individual value of radiosensitivity and could predict late toxicity due to radiotherapy. Other prospective studies with higher number of patients are needed to validate these results.
Figures


Similar articles
-
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.Radiat Oncol. 2011 Jun 6;6:60. doi: 10.1186/1748-717X-6-60. Radiat Oncol. 2011. PMID: 21645372 Free PMC article.
-
Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients.Strahlenther Onkol. 2014 Feb;190(2):210-6. doi: 10.1007/s00066-013-0488-x. Epub 2013 Dec 22. Strahlenther Onkol. 2014. PMID: 24362501
-
Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs).Radiat Oncol. 2010 Jan 28;5:4. doi: 10.1186/1748-717X-5-4. Radiat Oncol. 2010. PMID: 20109191 Free PMC article.
-
Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients.Radiat Oncol. 2010 Sep 24;5:85. doi: 10.1186/1748-717X-5-85. Radiat Oncol. 2010. PMID: 20868468 Free PMC article.
-
Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?Cancer Radiother. 2024 Oct;28(5):442-448. doi: 10.1016/j.canrad.2024.06.002. Epub 2024 Sep 19. Cancer Radiother. 2024. PMID: 39304399 Review.
Cited by
-
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.Radiat Oncol. 2011 Jun 6;6:60. doi: 10.1186/1748-717X-6-60. Radiat Oncol. 2011. PMID: 21645372 Free PMC article.
-
Annexin V FITC conjugated as a radiation toxicity indicator in lymphocytes following radiation overexposure in radiotherapy programs.Adv Biomed Res. 2015 Jun 4;4:119. doi: 10.4103/2277-9175.158025. eCollection 2015. Adv Biomed Res. 2015. PMID: 26261821 Free PMC article.
-
Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response.J Clin Med. 2022 Aug 23;11(17):4947. doi: 10.3390/jcm11174947. J Clin Med. 2022. PMID: 36078877 Free PMC article.
-
Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients.Strahlenther Onkol. 2014 Feb;190(2):210-6. doi: 10.1007/s00066-013-0488-x. Epub 2013 Dec 22. Strahlenther Onkol. 2014. PMID: 24362501
-
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.Front Oncol. 2018 Apr 5;8:83. doi: 10.3389/fonc.2018.00083. eCollection 2018. Front Oncol. 2018. PMID: 29675397 Free PMC article. Review.
References
-
- Fernet M, Hall J. Predictive markers for normal tissue reactions: fantasy or reality? Cancer Radiother. 2008;12:614–618. - PubMed
-
- Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;48:745–750. - PubMed
-
- Buchholz TA. Finding our sensitive patients. Int J Radiat Oncol Biol Phys. 1999;45:547–548. - PubMed
-
- Henriquez Hernandez LA, Lara PC, Pinar B, Bordon E, Rodriguez Gallego C, Bilbao C, Fernandez Perez L, Flores Morales A. Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiat Oncol. 2009;4:17. doi: 10.1186/1748-717X-4-17. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous